- Posted Monday May 4, 2015
MICR explores ways to increase the number, participation, visibility and recognition of minority scientists in cancer research
PHOENIX, Ariz. - May 4, 2015 - Dr. Lisa
Baumbach-Reardon, an Associate Professor at the Translational
Genomics Research Institute (TGen), has been elected to the
Minorities in Cancer Research (MICR) Council of the American
Association of Cancer Research (AACR).
Dr. Baumbach-Reardon, who heads her own lab in TGen's Integrated Cancer Genomics Division, was elected to a 3-year term on the MICR Council, which acts as an advisory body to the AACR leadership on issues of concern to minority investigators, and is also responsible fororganizing the activities of MICR through its committees.
MICR consists of nearly 4,000 members of AACR who are interested in exploring ways to increase the number, participation, visibility and recognition of minority scientists in the cancer research field, and within AACR.
Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates in 97 countries.
"Lisa's election to the MICR Council is an honor and an opportunity for her to share her passion for overcoming ethnic disparities - both for patients, and for the cancer researchers and oncologists who care for them," said Dr. John Carpten, TGen Deputy Director of Basic Science, who has previously served on the MICR Council.
The MICR Council is made up of13 elected members who annually elect achairperson and threenew council members.
"I am very honored to be elected to the MICR Council," said Dr. Baumbach-Reardon, who has been active in AACR and MICR for nearly a decade. "I have witnessed how MICR has increased awareness and understanding of disparities in cancer across ethnicities."
Her main focus in cancer research has been a heightened understanding of the genetic and genomic basis of breast cancer in women of African ancestry.
"My research and passion in this area go hand-in-hand," Dr. Baumbach-Reardon said. "I will follow in the footsteps of previous MICR Council members and leaders, such as Dr. John Carpten, and look forward to upcoming opportunities to serve the AACR and members of the MICR section."
Dr. Baumbach-Reardon is certified in Molecular and Biochemical Genetics by the American Board of Medical Genetics (ABMG).She has been a leader in molecular genetics training for young scientists and currently holds an adjunct faculty position in the Molecular & Cellular Biology program at Arizona State University (ASU).
She has published numerous articles in the field of human molecular genetics, and currently serves as an ad-hoc reviewer for a number of scientific journals and grant review study sections. Her main research areas are the genetic basis of African-American breast cancer, and the molecular basis of a number of inherited neurological and neuromuscular diseases.
To facilitate its mission, MICR meets the needs of minority scientists by:
• Increasing the number, participation, visibility, and recognition of minority scientists in cancer research;
• Developing programs that address the professional needs of minority scientists in cancer research;
• Providing diversity in the field and within the AACR's membership, programs, committees, and leadership;
• Addressing the disparities in cancer incidence and mortality faced by minorities and the medically underserved;
• Advocating for relevant, effective legislation pertaining to science and public policy in consultation with the Science Policy and Legislative Affairs Committee; and
• Assuming other such roles as are deemed necessary or appropriate to MICR's mission.
# # #
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit:www.tgen.org.
TGen Senior Science Writer
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in 97 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with over 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org. Follow us: Cancer Research Catalyst http://blog.aacr.org; Twitter @AACR; and Facebook http://www.facebook.com/aacr.org